327 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 25850966 | Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. | 2015 Jun | 9 |
52 | 25873594 | Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction. | 2015 Jul | 2 |
53 | 26106364 | Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding. | 2015 | 7 |
54 | 26146874 | Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. | 2015 Oct | 1 |
55 | 26598579 | Classic Studies on the Interaction of Cocaine and the Dopamine Transporter. | 2015 Dec 31 | 5 |
56 | 23856832 | Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT. | 2014 Feb | 1 |
57 | 24102293 | Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine. | 2014 Jan | 9 |
58 | 24269640 | Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge. | 2014 Jul | 1 |
59 | 24566123 | Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter. | 2014 May | 11 |
60 | 24576496 | Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation. | 2014 Jul | 3 |
61 | 24649839 | Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine. | 2014 Mar | 2 |
62 | 24792462 | Vascular effects of diphenylmethoxypiperidine-derived dopamine uptake inhibitors. | 2014 Jun 1 | 1 |
63 | 24947061 | Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan). | 2014 Aug | 2 |
64 | 24953830 | Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine. | 2014 Dec | 6 |
65 | 25247548 | Crack cocaine users show differences in genotype frequencies of the 3' UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3). | 2014 | 3 |
66 | 25339174 | A conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporter. | 2014 Dec 12 | 1 |
67 | 23042662 | Application of feedback-controlled bolus plus infusion (FC-B/I) method for quantitative PET imaging of dopamine transporters with [(18)F]β-CFT-FE in conscious monkey brain. | 2013 Jan | 3 |
68 | 23170765 | Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. | 2013 Apr | 1 |
69 | 23340505 | Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. | 2013 Jan 22 | 4 |
70 | 23660705 | Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter. | 2013 Oct | 2 |
71 | 23719505 | Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter. | 2013 Nov | 8 |
72 | 23731497 | Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. | 2013 Dec | 1 |
73 | 24285320 | Tropane-derived (11) C-labelled and (18) F-labelled DAT ligands. | 2013 Mar-Apr | 1 |
74 | 22514303 | Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. | 2012 Apr 18 | 1 |
75 | 22715379 | A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation. | 2012 | 1 |
76 | 23079638 | Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters. | 2012 Sep | 3 |
77 | 20801429 | Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. | 2011 Feb 1 | 8 |
78 | 20969853 | Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins. | 2011 Jan 15 | 1 |
79 | 21146984 | The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes. | 2011 Jan 1 | 2 |
80 | 21251927 | A catecholamine transporter from the human parasite Schistosoma mansoni with low affinity for psychostimulants. | 2011 May | 1 |
81 | 21272013 | VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. | 2011 Jan | 1 |
82 | 21298009 | The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter. | 2011 Jan 27 | 2 |
83 | 21402130 | Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection. | 2011 May 19 | 3 |
84 | 21420984 | Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113. | 2011 Jul-Aug | 5 |
85 | 21717292 | Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. | 2011 Aug | 1 |
86 | 21785269 | Mimicking synaptic effects of addictive drugs with selective dopamine neuron stimulation. | 2011 Nov-Dec | 2 |
87 | 21859929 | Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. | 2011 Nov | 3 |
88 | 22043293 | The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. | 2011 | 1 |
89 | 19899168 | Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer. | 2010 Mar | 2 |
90 | 20085610 | Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. | 2010 Apr | 2 |
91 | 20201860 | Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse. | 2010 Feb | 2 |
92 | 20352074 | Receptor-Based Discovery of a Plasmalemmal Monoamine Transporter Inhibitor via High Throughput Docking and Pharmacophore Modeling. | 2010 Mar 17 | 3 |
93 | 20364374 | Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models. | 2010 May | 1 |
94 | 20551317 | Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons. | 2010 Aug 27 | 2 |
95 | 20688912 | Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. | 2010 Oct 15 | 4 |
96 | 20715493 | [Methylphenidate: pharmacology, indication and potential of abuse]. | 2010 Aug | 1 |
97 | 20801583 | Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions. | 2010 Dec | 2 |
98 | 20830722 | The DAT ligand [(18)F]PR17.MZ mirrors the in vivo pharmacokinetic profile of [(11)C]cocaine with significantly improved monoamine transporter selectivity. | 2010 Oct 4 | 1 |
99 | 20840845 | The selective dopamine uptake inhibitor, D-84, suppresses cocaine self-administration, but does not occasion cocaine-like levels of generalization. | 2010 Dec 1 | 2 |
100 | 19038779 | Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation. | 2009 Mar | 1 |